AbCellera Biologics Inc - ABCL - stock price prediction, stock price target, analyst ratings from 9 analysts

AbCellera Biologics Inc has a share price target of US$ 8, revenue growth forecast of -9.6%, and profit growth estimate of -20.3% for FY25, based on top 9 analyst calls.